Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus

Author： Jorquera Patricia A.   Tripp Ralph A.  

Publisher： MDPI

E-ISSN： 2076-393x|4|4|45-45

ISSN： 2076-393x

Source： Vaccines, Vol.4, Iss.4, 2016-12, pp. : 45-45

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Respiratory Syncytial Virus: Current Progress in Vaccine Development

By Rudraraju Rajeev   Jones Bart G.   Sealy Robert   Surman Sherri L.   Hurwitz Julia L.  

Viruses, Vol. 5, Iss. 2, 2013-02 ,pp. : 577-594

MDPI

Access to resources Recommend Favorite

Th17 Lymphocytes in Respiratory Syncytial Virus Infection

By Bystrom Jonas   Al-Adhoubi Nasra   Al-Bogami Mohammed   Jawad Ali S.   Mageed Rizgar A.  

Viruses, Vol. 5, Iss. 3, 2013-03 ,pp. : 777-791

MDPI

Access to resources Recommend Favorite

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

By Altenburg Arwen F.   Kreijtz Joost H. C. M.   de Vries Rory D.   Song Fei   Fux Robert   Rimmelzwaan Guus F.   Sutter Gerd   Volz Asisa  

Viruses, Vol. 6, Iss. 7, 2014-07 ,pp. : 2735-2761

MDPI

Access to resources Recommend Favorite

Virus-Like-Vaccines against HIV

By Andersson Anne-Marie C.   Schwerdtfeger Melanie   Holst Peter J.  

Vaccines, Vol. 6, Iss. 1, 2018-02 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite

Transmission of Human Respiratory Syncytial Virus in the Immunocompromised Ferret Model

By de Waal Leon   Smits Saskia L.   Veldhuis Kroeze Edwin J. B.   van Amerongen Geert   Pohl Marie O.   Osterhaus Albert D. M. E.   Stittelaar Koert J.  

Viruses, Vol. 10, Iss. 1, 2018-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite